Spike-Independent Infection of Human Coronavirus 229E in Bat Cells. 2023

Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.

Bats are the reservoir for numerous human pathogens, including coronaviruses. Despite many coronaviruses having descended from bat ancestors, little is known about virus-host interactions and broader evolutionary history involving bats. Studies have largely focused on the zoonotic potential of coronaviruses with few infection experiments conducted in bat cells. To determine genetic changes derived from replication in bat cells and possibly identify potential novel evolutionary pathways for zoonotic virus emergence, we serially passaged six human 229E isolates in a newly established Rhinolophus lepidus (horseshoe bat) kidney cell line. Here, we observed extensive deletions within the spike and open reading frame 4 (ORF4) genes of five 229E viruses after passaging in bat cells. As a result, spike protein expression and infectivity of human cells was lost in 5 of 6 viruses, but the capability to infect bat cells was maintained. Only viruses that expressed the spike protein could be neutralized by 229E spike-specific antibodies in human cells, whereas there was no neutralizing effect on viruses that did not express the spike protein inoculated on bat cells. However, one isolate acquired an early stop codon, abrogating spike expression but maintaining infection in bat cells. After passaging this isolate in human cells, spike expression was restored due to acquisition of nucleotide insertions among virus subpopulations. Spike-independent infection of human coronavirus 229E may provide an alternative mechanism for viral maintenance in bats that does not rely on the compatibility of viral surface proteins and known cellular entry receptors. IMPORTANCE Many viruses, including coronaviruses, originated from bats. Yet, we know little about how these viruses switch between hosts and enter human populations. Coronaviruses have succeeded in establishing in humans at least five times, including endemic coronaviruses and the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In an approach to identify requirements for host switches, we established a bat cell line and adapted human coronavirus 229E viruses by serial passage. The resulting viruses lost their spike protein but maintained the ability to infect bat cells, but not human cells. Maintenance of 229E viruses in bat cells appears to be independent of a canonical spike receptor match, which in turn might facilitate cross-species transmission in bats.

UI MeSH Term Description Entries
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D002685 Chiroptera Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats. Bats,Flying Foxes,Horseshoe Bats,Pteropodidae,Pteropus,Rhinolophus,Rousettus,Bat, Horseshoe,Bats, Horseshoe,Foxes, Flying,Horseshoe Bat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D028941 Coronavirus 229E, Human A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It lacks hemagglutinin-esterase. HCoV-229E,Human Coronavirus 229E
D064370 Spike Glycoprotein, Coronavirus A class I viral fusion protein that forms the characteristic spikes, or peplomers, found on the viral surface that mediate virus attachment, fusion, and entry into the host cell. During virus maturation, it is cleaved into two subunits: S1, which binds to receptors in the host cell, and S2, which mediates membrane fusion. Spike Glycoprotein, Bovine Coronavirus,Spike Glycoproteins, Coronavirus,E2 Spike Glycoprotein, Coronavirus,Glycoprotein S, Coronavirus,Spike Glycoprotein S1, Coronavirus,Spike Protein S2, Coronavirus,Spike Protein, Coronavirus,Coronavirus Spike Glycoprotein,Coronavirus Spike Protein

Related Publications

Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
September 2021, Pharmaceuticals (Basel, Switzerland),
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
March 2012, The Journal of general virology,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
December 2007, Virus research,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
August 1998, Journal of virology,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
January 1993, Advances in experimental medicine and biology,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
January 2017, NPJ genomic medicine,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
May 1990, The Journal of general virology,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
March 2017, PLoS pathogens,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
October 2022, Cell reports,
Marcus G Mah, and Martin Linster, and Dolyce H W Low, and Yan Zhuang, and Jayanthi Jayakumar, and Firdaus Samsudin, and Foong Ying Wong, and Peter J Bond, and Ian H Mendenhall, and Yvonne C F Su, and Gavin J D Smith
March 2008, The Journal of infectious diseases,
Copied contents to your clipboard!